3.49
price up icon3.25%   0.11
after-market 시간 외 거래: 3.54 0.05 +1.43%
loading
전일 마감가:
$3.38
열려 있는:
$3.39
하루 거래량:
33,553
Relative Volume:
1.36
시가총액:
$8.00M
수익:
$2.98M
순이익/손실:
$-2.68M
주가수익비율:
-2.1601
EPS:
-1.6157
순현금흐름:
$-2.29M
1주 성능:
+10.79%
1개월 성능:
+3.25%
6개월 성능:
-20.50%
1년 성능:
+44.81%
1일 변동 폭
Value
$3.3319
$3.6799
1주일 범위
Value
$2.9452
$3.6799
52주 변동 폭
Value
$1.90
$13.93

Xenetic Biosciences Inc Stock (XBIO) Company Profile

Name
명칭
Xenetic Biosciences Inc
Name
전화
781-778-7720
Name
주소
945 CONCORD ST., FRAMINGHAM, MA
Name
직원
2
Name
트위터
@XeneticBio
Name
다음 수익 날짜
2026-03-17
Name
최신 SEC 제출 서류
Name
XBIO's Discussions on Twitter

Compare XBIO vs VRTX, REGN, ARGX, ALNY, ONC

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
XBIO icon
XBIO
Xenetic Biosciences Inc
3.49 7.74M 2.98M -2.68M -2.29M -1.6157
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
435.65 112.35B 12.07B 3.95B 3.19B 15.33
REGN icon
REGN
Regeneron Pharmaceuticals Inc
746.00 79.71B 14.34B 4.50B 3.77B 41.56
ARGX icon
ARGX
Argen X Se Adr
828.35 52.29B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
320.13 44.48B 3.71B 313.75M 465.38M 2.2571
ONC icon
ONC
Beone Medicines Ltd Adr
320.70 35.51B 5.36B 287.73M 924.18M 2.5229

Xenetic Biosciences Inc Stock (XBIO) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2020-01-08 개시 Maxim Group Buy

Xenetic Biosciences Inc 주식(XBIO)의 최신 뉴스

pulisher
Apr 13, 2026

Investment Report: Can Xenetic Biosciences Inc maintain sales growth2026 Valuation Update & Breakout Confirmation Alerts - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 13, 2026

Published on: 2026-04-13 21:59:57 - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 08, 2026

History Review: Is Xenetic Biosciences Inc stock good for income investors2026 Patterns & Fast Exit and Entry Trade Guides - baoquankhu1.vn

Apr 08, 2026
pulisher
Apr 08, 2026

Sectors Review: Is Xenetic Biosciences Inc stock undervalued right nowTrade Risk Summary & Verified Momentum Watchlists - baoquankhu1.vn

Apr 08, 2026
pulisher
Apr 07, 2026

Loss Report: Is Xenetic Biosciences Inc a potential multi baggerWeekly Risk Report & Risk Controlled Stock Alerts - baoquankhu1.vn

Apr 07, 2026
pulisher
Apr 04, 2026

XBIO PE Ratio & Valuation, Is XBIO Overvalued - Intellectia AI

Apr 04, 2026
pulisher
Apr 04, 2026

XBIO.WS (Xenetic Biosciences) PB Ratio : (As of Apr. 04, 2026) - gurufocus.com

Apr 04, 2026
pulisher
Apr 02, 2026

Highs Report: Is now the right time to enter Xenetic Biosciences Inc2026 PreEarnings & Weekly High Conviction Ideas - baoquankhu1.vn

Apr 02, 2026
pulisher
Mar 30, 2026

Xenetic Biosciences, Inc. (NASDAQ:XBIO) Short Interest Update - Defense World

Mar 30, 2026
pulisher
Mar 27, 2026

Published on: 2026-03-27 18:33:00 - baoquankhu1.vn

Mar 27, 2026
pulisher
Mar 26, 2026

Aug Volume: Is Xenetic Biosciences Inc on track to beat earningsQuarterly Growth Report & Verified Short-Term Plans - baoquankhu1.vn

Mar 26, 2026
pulisher
Mar 22, 2026

Analyst Calls: Can Xenetic Biosciences Inc be recession proof2026 Valuation Update & Long-Term Safe Investment Ideas - baoquankhu1.vn

Mar 22, 2026
pulisher
Mar 13, 2026

Xenetic (XBIO) Reports Increased Revenue and Advances Clinical D - GuruFocus

Mar 13, 2026
pulisher
Mar 13, 2026

Xenetic Biosciences, Inc. Reports Full Year 2025 Financial Results - Bitget

Mar 13, 2026
pulisher
Mar 13, 2026

[8-K] Xenetic Biosciences, Inc. Reports Material Event | XBIO SEC FilingForm 8-K - Stock Titan

Mar 13, 2026
pulisher
Mar 13, 2026

Cancer biotech Xenetic grows Takeda royalties to $3M, trims costs - Stock Titan

Mar 13, 2026
pulisher
Mar 12, 2026

Xenetic Biosciences: Fourth Quarter Financial Results Overview - Bitget

Mar 12, 2026
pulisher
Mar 12, 2026

Xenetic Biosciences 2025 Annual Report: Advancing DNase Immuno-Oncology Technology for Solid Tumors and Strategic Business Developments - Minichart

Mar 12, 2026
pulisher
Mar 12, 2026

Xenetic Biosciences: Q4 Earnings Snapshot - KTVB

Mar 12, 2026
pulisher
Mar 12, 2026

XBIO: Revenue up 19%, net loss narrows, DNase oncology focus, strategic review underway - TradingView

Mar 12, 2026
pulisher
Mar 12, 2026

Xenetic Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 12, 2026
pulisher
Mar 07, 2026

XBIO SEC FilingsXenetic Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 07, 2026
pulisher
Mar 06, 2026

Risk On: Can Xenetic Biosciences Inc be recession proofWeekly Profit Summary & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 06, 2026

Big Money Moves: Is Xenetic Biosciences Inc stock a value trapJuly 2025 Retail & Community Consensus Stock Picks - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 06, 2026

Published on: 2026-03-07 03:26:22 - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 06, 2026

Xenetic Biosciences adjourns 2025 annual meeting - MSN

Mar 06, 2026
pulisher
Mar 05, 2026

Can Xenetic Biosciences Inc be recession proofTrade Performance Summary & Fast Gain Stock Tips - baoquankhu1.vn

Mar 05, 2026
pulisher
Mar 04, 2026

XBIO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 04, 2026
pulisher
Mar 02, 2026

Analyst Downgrade: Can Xenetic Biosciences Inc be recession proofQuarterly Investment Review & Safe Capital Allocation Plans - baoquankhu1.vn

Mar 02, 2026
pulisher
Mar 01, 2026

XBIO Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Mar 01, 2026
pulisher
Mar 01, 2026

Xenetic Biosciences, Inc. Reports Second Quarter 2025 Financial Results - Montgomery Advertiser

Mar 01, 2026
pulisher
Feb 27, 2026

XBIO Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Feb 27, 2026
pulisher
Feb 27, 2026

Xenetic Biosciences Inc. (XBIO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Feb 27, 2026
pulisher
Feb 27, 2026

XBIO Should I Buy - Intellectia AI

Feb 27, 2026
pulisher
Feb 26, 2026

Xenetic Biosciences, Inc. (NASDAQ:XBIO) Sees Large Increase in Short Interest - Defense World

Feb 26, 2026
pulisher
Feb 24, 2026

Trading Recap: Is AMKR stock a value trapWeekly Loss Report & Growth Focused Stock Reports - baoquankhu1.vn

Feb 24, 2026
pulisher
Feb 23, 2026

Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting - Independent Mail

Feb 23, 2026
pulisher
Feb 23, 2026

Is Xenetic Biosciences Inc stock undervalued right now2025 Sector Review & Technical Buy Zone Confirmations - baoquankhu1.vn

Feb 23, 2026
pulisher
Feb 21, 2026

Aug Analyst Calls: Is now the right time to enter Xenetic Biosciences IncJuly 2025 Pullbacks & Safe Entry Trade Reports - baoquankhu1.vn

Feb 21, 2026
pulisher
Feb 19, 2026

Technical Analysis: Is VRMEW affected by consumer sentimentChart Signals & Growth Focused Stock Pick Reports - baoquankhu1.vn

Feb 19, 2026
pulisher
Feb 18, 2026

Can Xenetic Biosciences Inc. stock deliver strong Q4 earnings2025 Retail Activity & Safe Swing Trade Setup Alerts - mfd.ru

Feb 18, 2026
pulisher
Feb 18, 2026

Investor Mood: Whats the outlook for Xenetic Biosciences Incs sectorWeekly Risk Summary & Weekly Stock Breakout Alerts - baoquankhu1.vn

Feb 18, 2026
pulisher
Feb 17, 2026

Trend Report: Whats the profit margin of Xenetic Biosciences Inc2025 EndofYear Setup & Community Verified Swing Trade Signals - baoquankhu1.vn

Feb 17, 2026
pulisher
Feb 16, 2026

Aug PreEarnings: Can Xenetic Biosciences Inc maintain sales growthWeekly Stock Report & Growth Oriented Trade Recommendations - baoquankhu1.vn

Feb 16, 2026
pulisher
Feb 16, 2026

Support Test: Is National Energy Services Reunited Corp gaining market shareMarket Growth Report & AI Driven Stock Price Forecasts - baoquankhu1.vn

Feb 16, 2026
pulisher
Feb 15, 2026

Can Xenetic Biosciences Inc. be recession proofGDP Growth & Growth Focused Stock Pick Reports - mfd.ru

Feb 15, 2026
pulisher
Feb 15, 2026

How cyclical is Xenetic Biosciences Inc.’s revenue streamEarnings Overview Report & Smart Money Movement Tracker - mfd.ru

Feb 15, 2026
pulisher
Feb 14, 2026

Is Xenetic Biosciences Inc. stock undervalued right nowRate Cut & Real-Time Price Movement Reports - mfd.ru

Feb 14, 2026
pulisher
Feb 12, 2026

Xenetic Biosciences appoints James Parslow as interim CEO - Intellectia AI

Feb 12, 2026
pulisher
Feb 12, 2026

Renaissance holds 7.79% of Xenetic Biosciences (XBIO) shares - Stock Titan

Feb 12, 2026
pulisher
Feb 11, 2026

Aug Drivers: Can Xenetic Biosciences Inc be recession proofTrade Performance Summary & Long-Term Safe Investment Plans - baoquankhu1.vn

Feb 11, 2026

Xenetic Biosciences Inc (XBIO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$53.49
price down icon 1.39%
$48.48
price down icon 0.45%
$101.32
price up icon 1.82%
$149.69
price down icon 1.95%
$142.78
price down icon 2.70%
ONC ONC
$319.61
price down icon 0.07%
자본화:     |  볼륨(24시간):